Allergan (Irvine, California) reported completing the integration of the operations of Inamed , uniting the companies' facial aesthetics, breast aesthetics and obesity intervention product portfolios under the Allergan name and within a newly established division, Allergan Medical .

Allergan completed its purchase of Inamed in March (Medical Device Daily, March 24, 2006).

"Unifying Inamed's assets and resources under the Allergan name will enable us to maximize our combined strengths and move forward as one company with one vision for the future," said David Pyott, CEO and chairman of Allergan, adding praise for the company's "Science of Rejuvenation and Wellness' leadership."

Allergan's key franchises in neurosciences, ophthalmology, and dermatology remain structured under the company's core pharma portfolio. Its existing aesthetics franchise, including Botox, has been aligned within Allergan Medical along with the former Inamed Aesthetics product portfolio, which includes hyaluronic acid and collagen-based dermal fillers and breast implants.

Allergan Medical also encompasses the former Inamed Health product portfolio, including the BioEnterics LAP-BAND adjustable gastric banding system, a minimally invasive surgical device used to treat obesity.

While Allergan's headquarters remain in Irvine, the company is retaining a presence in Santa Barbara to maintain a national center of excellence focused on medical aesthetics R&D, customer and patient service, and quality assurance. Internationally, Allergan is integrating the Inamed businesses into Allergan's existing structure to generate opportunities with the Vistabel product, the brand name for Botox in Europe.

Robert Grant, president/vice president of Allergan Medical, said, "It's a very exciting time as we are launching our next generation dermal filler, Juvederm, recently approved by the U.S. Food and Drug Administration. It is the first product resulting from the combined companies' pipeline."